FOLH1 and neoplasm: The improved clearance rate may bring us closer to the theranostics of [68Ga]Ga/[177Lu]Lu-PSMA-X on the premise of achieving tumor uptake comparable to that of [68Ga]Ga/[177Lu]Lu-PSMA-617, which was the ultimate goal of our study.